Simulations Plus to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
2024年8月28日 - 9:30PM
ビジネスワイヤ(英語)
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a
leading provider of biosimulation, simulation-enabled performance
and intelligence solutions, and medical communications for the
biopharma industry, today announced that Shawn O’Connor, chief
executive officer, will participate in the Morgan Stanley 22nd
Annual Global Healthcare Conference at the Marriott Marquis New
York, on Friday, September 6, 2024. Mr. O’Connor will host
one-on-one and small group meetings throughout the day.
This event is expected to include more than 200 companies as
well as a preeminent group of investor attendees, including chief
investment officers, portfolio managers and analysts. For more
information about the conference, please visit the Morgan Stanley
conference website.
About Simulations Plus
With more than 25 years of experience serving clients globally,
Simulations Plus stands as a premier provider in the Biopharma
sector, offering advanced software and consulting services that
enhance drug discovery, development, research, clinical trial
operations, regulatory submissions, and commercialization. Our
comprehensive biosimulation solutions integrate artificial
intelligence/machine learning (AI/ML), physiologically based
pharmacokinetics, physiologically based biopharmaceutics,
quantitative systems pharmacology/toxicology, and population PK/PD
modeling approaches. We also deliver simulation-enabled performance
and intelligence solutions alongside medical communications support
for clinical and commercial drug development. Our cutting-edge
technology is licensed and utilized by leading pharmaceutical,
biotechnology, and regulatory agencies worldwide. For more
information, visit our website at www.simulations-plus.com. Follow
us on LinkedIn | X | YouTube.
Environmental, Social, and Governance (ESG)
We focus our Environmental, Social, and Governance (ESG) efforts
where we can have the most positive impact. To learn more about our
latest initiatives and priorities, please visit our website to read
our 2023 ESG update.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240828878863/en/
Investor Relations Contacts:
Lisa Fortuna Financial Profiles 310-622-8251
slp@finprofiles.com
Renee Bouche Simulations Plus Investor Relations 661-723-7723
renee.bouche@simulations-plus.com
Simulations Plus (NASDAQ:SLP)
過去 株価チャート
から 9 2024 まで 10 2024
Simulations Plus (NASDAQ:SLP)
過去 株価チャート
から 10 2023 まで 10 2024